[Pathophysiology of ulcer disease].
The pathophysiological structure shows aggressors like increased acid and pepsin, an impaired defence system of the mucosa (mucus, mucosal circulation and possibly PG's and epidermal growth hormone). Disturbances in the interdigestive and digestive motility brings about most clearly the pathophysiological differences between GU and DU. Therapeutic corrections of the high secretion lead to pathological reactions in other parts of the system (gastrin). SPV is the only therapeutic procedure which reduces irreversibly the enlarged secretory capacity of the gastric mucosa (parietal cell reduction). This surgical treatment should therefore have priority in the treatment also of uncomplicated duodenal ulcers and with some exceptions of GU.
G E
GE
Holle
D004381:Duodenal Ulcer / Q000503:physiopathology* / Q000601:surgery; D004815:Epidermal Growth Factor / Q000502:physiology; D004848:Epithelium / Q000503:physiopathology; D005744:Gastric Acid / Q000378:metabolism; D005746:Gastric Emptying; D005753:Gastric Mucosa / Q000503:physiopathology; D005769:Gastrointestinal Motility; D006636:Histamine Release; D006801:Humans; D008564:Membrane Potentials; D011183:Postoperative Complications / Q000503:physiopathology; D011453:Prostaglandins / Q000502:physiology; D013276:Stomach Ulcer / Q000503:physiopathology* / Q000601:surgery; D014629:Vagotomy, Proximal Gastric
D011453:Prostaglandins; D004815:Epidermal Growth Factor
Die Pathophysiologie der Ulcuskrankheit.